Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) and colon cancer-associated transcript 2 (CCAT2) are acted as biomarkers in patients with lung cancer [20–22]. This evidence concerns the gene MALAT1 and lung cancer.